Urine lipoarabinomannan as initial markers for active pulmonary tuberculosis

Australian Journal of Basic and Applied Sciences

Volumn 6, Issue 3, 2012, Pages 751-755

  Elsawy, Abdelrahman ^a   Redwan, Elrashdy M ^b,c  

^a AL AZHAR UNIVERSITY   (Egypt)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c Universities and Research Institutes District   (Egypt)

Author keywords

Diagnosis; Human urine; Lipoarabinomannan; M. tuberculosis

Indexed keywords

EID: 84864755284     PISSN: 19918178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Boehme, C., E. Molokova, F. Minja, S. Geis, T. Loscher, L. Maboko, V. Koulchin, M. Hoelscher, 2005. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Transaction Royal Society Tropical Medicine and Hygene, 99: 893-900.
2. Chan, E.D., R. Reves, J.T. Belisle, P.J.K. Brennan and W.E. Hahn, 2000. Diagnosis of Tuberculosis by a Visually Detectable Immunoassay for Lipoarabinomannan. American Journal Respiratory Critical Care Medicine, 161: 1713-1719.
3. Corper, H.J., 1928. The certified diagnosis of tuberculosis. Practical evaluation of a new method for cultivating tubercle bacilli for diagnostic purposes. Journal American Medicine Association, 91: 371-00.
4. Daley, P., J.S. Michael, P. Hmar, A. Latha, P. Chordia, D. Mathai, K.R. John and M. Pai, 2009. Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. The International Journal Tuberculosis lung Diseases, 13(8): 989-995.
5. Dheda, K., V. Davids, L. Lenders, T. Roberts, R. Meldau, D. Ling, L. Brunet, Z. Smit, J. Peter, C. Green, M. Badri, L. Sechi, S. Sharma, M. Hoelscher, R. Dawson, A. Whitelaw, J. Blackburn, M. Pai, A. Zumla, 2010. Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples. PLoS ONE, 5(3): e9848.
6. Dheda, K., R.Z. Smit, M. Badri, M. Pai, 2009. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high burden vs. low-burden settings. Current Opinion Pulmonary Medicine, 15: 188-200.
7. Dheda, K., R.N. Van-Zyl Smit, L.A. Sechi, M. Badri, R. Meldau, G. Symons, H. Khalfey, I. Carr, A. Maredza, R. Dawson, H. Wainright, A. Whitelaw, E.D. Bateman, A. Zumla, 2009. Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS One, 4: e4689.
8. Gerhardt, P., R.G. Murray, W.A. Wood and N.R. Krieg, 1994. Methods for general and molecular bacteriology. ASM Press, Washington, DC.
9. Hamasur, B., J. Bruchfeld, M. Haile, A. Pawlowski, B. Bjorvatn, G. Källenius, S.B. Svenson, 2001. Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. Journal Microbiological Methods, 45: 41-52.
10. Hunter, S.W., H. Gaylord and P.J. Brennan, 1986. Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. Journal Biological Chemistry, 261: 12345-12351.
11. Jessica, M., E. Leung, K. Talbot, M. Dheda1, Pai and D. Menzies, 2011. Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eurpean Respiratory Journal, 38: 1398-1405.
12. Lawn, S.D., D.J. Edwars, K. Kranzer, M. Vogt, L.G. Bekker, R. Wood, 2009. Urine lipoarabinomannan assay for tuberculosis screening prior to ART: diagnostic yield and association with immune reconstitution disease. AIDS, 23: 1875-80.
13. Maunank, S., E. Variava, C.B. Holmes, A. Coppin, J.A. Golub, J. McCallum, M. Wong, B. Luke, D.J. Martin, R.E. Chaisson, S.E. Dorman and N.A. Martinson, 2009. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a high HIV prevalence setting. Journal Acquire Immune Deficient Syndrome, 52(2): 145.
14. Mutetwa, R., C. Boehme, M. Dimairo, N. Mangeya1, D. Mungofa, D. Mangwanya, D. Makamure, P. Mason, S. Munyati and E. Corbett, 2009. Evaluation of a commercial urine lipoarabinomannan ELISA kit for diagnosis of TB in a high HIV prevalence setting. Presented at the 16th Conference on Retroviruses and Opportunistic Infections; February 8-11; Montréal, Canada.
15. Mutetwa, R., C. Boehme, M. Dimairo, D. Mangwanya, S. Munyati, D. Mangwanya, S. Mungofa, A.E. Butterworth, P.R. Mason, E.L. Corbett, 2009. Diagnostic accuracy of commercial urinary lipoarabinomannandetection in African TB suspects and patients. The International Journal of Tuberculosis and Lung Disease, 13(10): 1253-9.
16. Pai, M., S. Kalantri and K. Dheda, 2006. New tools and emerging technologies for the tuberculosis: part II. Active tuberculosis and drug resistance. Expert Review Molecular Diagnosis, 6: 423-432.
17. Patel, V.B., A.I. Bhigjee, H.F. Paruk, R. Singh, R. Meldau, C. Connolly, T. Ndung'u, R. Dheda, 2009. Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence setting. Cerebrospinal Fluid Research, 6: 13.
18. Redwan, R.M. and M.K. Al-Awady, 2002. Prevalence of tetanus immunity in the Egyptian population. Hum Antibodies, 11(1-2): 55-9.
19. Reither, K., E. Saathoff, J. Jung, L. Minja, I. Kroidl, E. Saad, J.F. Huggett, E.N. Ntinginya, L. Maganga, L. Maboko, M. Hoelscher, 2009. Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis. BMC Infectious Diseases, 9: 141-00.
20. Roach, T.I., H.C. Barton, D. Chatterjee and J.M. Blackwell, 1993. Macrophage activation: lipoarabinomannan from a virulent and virulent strains of M. tuberculosis deferentially induces the early genes cfos, KC, JE, and tumor necrosis factor alpha. J. Immunol., 150: 1886-1896.
21. Shah, M., E. Variava, C.B. Holmes, A. Coppin, J.E. Golub, J. McCallum, M. Wong, B. Luke, D.J. Martin, R.E. Chaisson, S.E. Dorman, N.A. Martinson, 2009. Diagnostic Accuracy of a Urine Lipoarabinomannan Test for Tuberculosis in Hospitalized Patients in a High HIV Prevalence Setting. Journal Acquire Immune Deficient Syndrome, 52(2): 145-51.
22. Tazir, M., H.L. David and F. Boulahbal, 1979. Evaluation of the chloride and bromide salts of cetylpyridinium for the transportation of sputum in tuberculosis bacteriology. Tubercle, 60: 31.
23. WHO, 2010. Global tuberculosis control: WHO report, WHO/HTM/TB/2010.7. WHO, Geneva, Switzerland.
24. Wilson, D., J. Nachega, C. Morroni, R. Chaisson and G. Maartens, 2006. Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults. The International Journal of Tuberculosis and Lung Disease, 10: 31-38.